Triple negative breast carcinoma is a prognostic factor in Taiwanese women

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Lin, Che ^a   Chien, Su Yu ^a   Chen, Li Sheng ^a   Kuo, Shou Jen ^a   Chang, Tsai Wang ^b   Chen, Dar Ren ^a  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CYCLOPHOSPHAMIDE; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; PACLITAXEL; PROGESTERONE RECEPTOR;

ADULT; AGE; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; TAIWAN; TUMOR VOLUME; BIOSYNTHESIS; BREAST TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE; TUMOR RECURRENCE;

BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL RATE; TAIWAN;

EID: 67651062544     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-192     Document Type: Article

References (23)

1. Alexe G Dalgin GS Scanfeld D Tamayo P Mesirov JP Ganesan S Delisi C Bhanot G Breast cancer stratification from analysis of micro-array data of micro-dissected specimens Genome Inform 2007, 18:130-140. 18546481
2. Horwitz KB Dye WW Harrell JC Kabos P Sartorius CA Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts Proc Natl Acad Sci USA 2008, 105:5774-5779. 2311360 18391223
3. Liedtke C Mazouni C Hess KR Andre F Tordai A Mejia JA Symmans WF Gonzalez-Angulo AM Hennessy B Green M Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer J Clin Oncol 2008, 26:1275-1281. 18250347
4. Yin WJ Lu JS Di GH Lin YP Zhou LH Liu GY Wu J Shen KW Han QX Shen ZZ Shao ZM Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients Breast Cancer Res Treat 2009, 115(2):325-33. 18563552 18563552
5. Cheang MC Voduc D Bajdik C Leung S McKinney S Chia SK Perou CM Nielsen TO Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype Clin Cancer Res 2008, 14:1368-1376. 18316557
6. Mersin H Yildirim E Berberoglu U Gulben K The prognostic importance of triple negative breast carcinoma Breast 2008, 17:341-346. 18450442
7. Nguyen PL Taghian AG Katz MS Niemierko A Abi Raad RF Boon WL Bellon JR Wong JS Smith BL Harris JR Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy J Clin Oncol 2008, 26:2373-2378. 18413639
8. Rakha EA Reis-Filho JS Ellis IO Basal-like breast cancer: A critical review J Clin Oncol 2008, 26(15):2568-81. 10.1200/JCO.2007.13.1748 18487574
9. Mehta RS Dose-dense and/or metronomic schedules of specific chemotherapies consolidate the chemosensitivity of triple-negative breast cancer: A step toward reversing triple-negative paradox J Clin Oncol 2008, 26:3286-3288. author reply 3288 18591566
10. Rakha EA El-Sayed ME Green AR Lee AH Robertson JF Ellis IO Prognostic markers in triple-negative breast cancer Cancer 2007, 109:25-32. 17146782
11. Siziopikou KP Ariga R Proussaloglou KE Gattuso P Cobleigh M The challenging estrogen receptor-negative/progesterone receptor-negative/ HER-2-negative patient: A promising candidate for epidermal growth factor receptor-targeted therapy? Breast J 2006, 12:360-362. 16848847
12. Kurebayashi J Moriya T Ishida T Hirakawa H Kurosumi M Akiyama F Kinoshita T Takei H Takahashi K Ikeda M Nakashima K The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races Breast 2007, 16(Suppl 2):S72-77. 17714947
13. Nishimura R Arima N Is triple negative a prognostic factor in breast cancer? Breast Cancer 2008, 15:303-308. 18369692
14. Haffty BG Yang Q Reiss M Kearney T Higgins SA Weidhaas J Harris L Hait W Toppmeyer D Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer J Clin Oncol 2006, 24:5652-5657. 17116942
15. Perreard L Fan C Quackenbush JF Mullins M Gauthier NP Nelson E Mone M Hansen H Buys SS Rasmussen K Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay Breast Cancer Res 2006, 8:R23. 1557722 16626501
16. Kim MJ Ro JY Ahn SH Kim HH Kim SB Gong G Clinicopathologic significance of the basal-like subtype of breast cancer: A comparison with hormone receptor and Her2/neu-overexpressing phenotypes Hum Pathol 2006, 37:1217-1226. 16938528
17. Fulford LG Reis-Filho JS Ryder K Jones C Gillett CE Hanby A Easton D Lakhani SR Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival Breast Cancer Res 2007, 9:R4. 1851397 17217540
18. Carey LA Perou CM Livasy CA Dressler LG Cowan D Conway K Karaca G Troester MA Tse CK Edmiston S Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 2006, 295:2492-2502. 16757721
19. Dent R Trudeau M Pritchard KI Hanna WM Kahn HK Sawka CA Lickley LA Rawlinson E Sun P Narod SA Triple-negative breast cancer: Clinical features and patterns of recurrence Clin Cancer Res 2007, 13:4429-4434. 17671126
20. Langerod A Zhao H Borgan O Nesland JM Bukholm IR Ikdahl T Karesen R Borresen-Dale AL Jeffrey SS TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer Breast Cancer Res 2007, 9:R30. 1929092 17504517
21. Rhee J Han SW Oh DY Kim JH Im SA Han W Park IA Noh DY Bang YJ Kim TY The Clinicopathologic Characteristics and Prognostic Significance of Triple-Negativity in Node-Negative Breast Cancer BMC Cancer 2008, 8:307. 2577689 18947390
22. Ryden L Landberg G Stal O Nordenskjold B Ferno M Bendahl PO HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information Breast Cancer Res Treat 2008, 109:351-357. 17636399
23. Kim HJ Cui X Hilsenbeck SG Lee AV Progesterone receptor loss correlates with human epidermal growth factor receptor 2 overexpression in estrogen receptor-positive breast cancer Clin Cancer Res 2006, 12:1013s-1018s. 16467118